PharmaVOICE - 
December 2003
Purchase Issue
In Every Issue
New electronic and web-based applications, sites, and technologies Solutions From [...]
Sales, marketing, And R&D Trends affecting the healthcare industry Profitable [...]
Today the pharmaceutical industry faces the challenge of deploying products [...]
Making a case for transformational product marketing Lena Chow Lena [...]
For Art’s Sake
The use of humor in pharmaceutical advertising, whether it is [...]
Letter from the Editor
letter from the editor Phase IV studies can help differentiate [...]

Taren Grom, Editor

What’s New
New healthcare-related products, services, and companies DVC Healthcare Launches Relationship- [...]
Talent Pool
executive appointments and promotions in the healthcare industry Pharma POOL [...]
What’s on Your Mind — Opinions
What’s on your mind opinions Preferred-provider status Increasingly, companies that [...]

On The Cover

The Value of Phase IV
BY Elisabeth Pena The Value of Phase IV Postmarketing research can be crucial for tracking side effects and exploring new uses for an approved drug. But these trials are heavily scrutinized because some say pharma companies have conducted such studies purely for promotional purposes with little scientific value. Phase IV trial results can help differentiate [...]

Elisabeth Pena


John Patton: A Lifetime of Adventure
by Kim Ribbink A Lifetime of Adventure With a number of ground- breaking technologies under its belt, Nektar Therapeutics is vying to be the No. 1 drug-delivery company in the world. And the company’s cofounder and chief scientific officer, John Patton, Ph.D., has led the push to unearth solutions to drug-delivery challenges that go beyond [...]

Kim Ribbink

NPs and PAs: A Growing Sphere of Influence
By Elisabeth Pena Sales reps are coming to us and providing us with good educational information, as well as the latest research data. Mary Kay Tucker The number of nurse practitioners and physician assistants empowered with the authority to prescribe medication is increasing annually. Addressing this group of healthcare practitioners represents additional opportunities for pharmaceutical [...]

Elisabeth Pena

The Art of Site Selection
By Denise Myshko The Art of Site Selection For pharmaceutical sponsors and their CRO partners, selecting the right investigator site is a linchpin to trial success. Quality sites have to have a well-trained staff, a patient-recruitment plan, experience in meeting or beating enrollment targets, low query rates, and quick turnaround. In my experience, site management [...]

Denise Myshko